The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,712.00
Bid: 2,050.00
Ask: 2,720.00
Change: 0.00 (0.00%)
Spread: 670.00 (32.683%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,712.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Issue of Notes

20 Feb 2024 08:41

RNS Number : 7649D
Coca-Cola HBC AG
20 February 2024

FOR IMMEDIATE RELEASE

Coca-Cola HBC Finance B.V.

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(a company incorporated with limited liability in Switzerland)

Launch of Issue of Notes

Zug, Switzerland and Amsterdam, The Netherlands - 20 February 2024 - Coca-Cola HBC Finance B.V. (the "Issuer") and Coca-Cola HBC AG ("Coca-Cola HBC") today announce the launch of a Euro denominated 4-year fixed-rate issue of Notes (the "Notes"), to be issued by the Issuer under its ?5,000,000,000 Euro Medium Term Note Programme, subject to market conditions.

The Notes will be guaranteed by Coca-Cola HBC.

This announcement must be read in conjunction with the Base Prospectus dated 19 December 2023, as supplemented on 15 February 2024 (the "Base Prospectus"), which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

Application will be made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the Regulated Market of the London Stock Exchange plc.

Disclaimer

Neither this announcement nor the Base Prospectus constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

Please note that the information contained in this announcement and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in this announcement and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in this announcement and/or the Base Prospectus is not addressed. Prior to relying on the information contained in this announcement and/or the Base Prospectus you must ascertain from this announcement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

Enquiries

Coca?Cola HBC Group

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Virginia Phillips

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager

Tel: +44 7597 562 978

claire.evans@cchellenic.com

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IODTMMPTMTITMMI
Date   Source Headline
15th Sep 20228:49 amRNSIssue of Debt
13th Sep 202212:38 pmRNSDirector/PDMR Shareholding
7th Sep 202212:05 pmRNSHolding(s) in Company
6th Sep 20222:03 pmRNSPublication of a Prospectus
30th Aug 20229:14 amRNSHolding(s) in Company
25th Aug 20229:01 amRNSHolding(s) in Company
23rd Aug 20221:45 pmRNSHolding(s) in Company
23rd Aug 202211:06 amRNSHolding(s) in Company
18th Aug 20223:43 pmRNSHolding(s) in Company
18th Aug 202212:05 pmRNSHolding(s) in Company
18th Aug 202211:24 amRNSDirector/PDMR Shareholding
11th Aug 202212:40 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSStrong volumes, revenue, EBIT; investing in growth
9th Aug 20221:45 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSCCH agrees to acquire Three Cents
19th Jul 202212:53 pmRNSDirector/PDMR Shareholding
19th Jul 202210:48 amRNSNotice of Results
22nd Jun 202210:45 amRNSHolding(s) in Company
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights
25th Jan 202212:50 pmRNSCompletes acquisition of further stake in CCBCE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.